Dentists in Napa, CA Accepting Medicare
106 Dentists found. Showing 101 - 106
 Daniel Lee, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1141 Pear Tree Ln Ste 120, Napa, CA 94558 Phone: 707-254-1770 |
Ricardo Flores, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1141 Pear Tree Ln, Napa, CA 94558 Phone: 831-637-5306 Fax: 707-254-1779 |
Dr. Andrew Joseph Zwers, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 1141 Pear Tree Ln Ste 120, Napa, CA 94558 Phone: 707-258-6128 |
Dr. Michael Haddad Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1230 Jefferson St, Napa, CA 94559 Phone: 818-974-7574 |
Mr. Robert Alan Grisham, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3257 Browns Valley Rd, Napa, CA 94558 Phone: 707-257-2800 Fax: 707-257-2218 |
Dr. Ralph William Moore Jr., DDS Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 3270 Beard Road, Napa, CA 94558 Phone: 707-252-6300 Fax: 707-252-8076 |
News Archive
Scientists discover reservoir of mitochondrial DNA mutations present in the general population
Researchers at the University of Newcastle, England, and the Virginia Bioinformatics Institute at Virginia Tech in the United States have revealed a large reservoir of mitochondrial DNA mutations present in the general population. Clinical analysis of blood samples from almost 3,000 infants born in north Cumbria, England, showed that at least 1 in 200 individuals in the general public harbor mitochondrial DNA mutations that may lead to disease.
AB SCIEX acquires liquid chromatography business of Eksigent Technologies
AB SCIEX, a global leader in life science analytical technologies, today announced that it has acquired the liquid chromatography business of Eksigent Technologies. This acquisition significantly strengthens AB SCIEX's position in liquid chromatography, which is a key technology used frequently in a broad range of life science applications such as protein biomarker research, drug discovery and basic research.
PharmAthene announces lifting of clinical hold on proposed SparVax Phase II study
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the U.S. Food and Drug Administration has lifted the clinical hold previously placed on a proposed Phase II study of SparVax, a next generation recombinant anthrax vaccine.
HHS unveils ACO details
During a Thursday morning press call, Health and Human Services Secretary Kathleen Sebelius and Centers for Medicare and Medicaid Services Administrator Donald Berwick unveiled the long-awaited federal rule on accountable care organizations.
Inorganic arsenic may increase the risk of developing type 2 diabetes
Inorganic arsenic, commonly found in ground water in certain areas, may increase the risk of developing type 2 diabetes, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health.
› Verified 1 days ago
Counselors
Psychologists
Clinical Social Workers
Dentists
Pharmacists
Occupational Therapists